Cough Plus Bronchial

Antimonium Tartaricum, Arum Triphyllum, Badiaga, Baptisia Tinctoria, Bryonia (alba), Drosera (rotundifolia), Echinacea (angustifolia), Eupatorium Perfoliatum, Kali Bromatum, Lung Suis, Phosphorus, Pulsatilla (pratensis), Spongia Tosta, Sticta Pulmonaria, Sulphur Iodatum, Urtica Urens


Liddell Laboratories, Inc.
Human Otc Drug
NDC 50845-0246
Cough Plus Bronchial also known as Antimonium Tartaricum, Arum Triphyllum, Badiaga, Baptisia Tinctoria, Bryonia (alba), Drosera (rotundifolia), Echinacea (angustifolia), Eupatorium Perfoliatum, Kali Bromatum, Lung Suis, Phosphorus, Pulsatilla (pratensis), Spongia Tosta, Sticta Pulmonaria, Sulphur Iodatum, Urtica Urens is a human otc drug labeled by 'Liddell Laboratories, Inc.'. National Drug Code (NDC) number for Cough Plus Bronchial is 50845-0246. This drug is available in dosage form of Spray. The names of the active, medicinal ingredients in Cough Plus Bronchial drug includes Anemone Pratensis - 30 [hp_C]/mL Antimony Potassium Tartrate - 200 [hp_C]/mL Arisaema Triphyllum Root - 30 [hp_C]/mL Baptisia Tinctoria Root - 3 [hp_X]/mL Bryonia Alba Root - 200 [hp_C]/mL Drosera Rotundifolia - 3 [hp_X]/mL Echinacea Angustifolia - 3 [hp_X]/mL Eupatorium Perfoliatum Flowering Top - 200 [hp_C]/mL Lobaria Pulmonaria - 200 [hp_C]/mL Phosphorus - 30 [hp_C]/mL and more. The currest status of Cough Plus Bronchial drug is Active.

Drug Information:

Drug NDC: 50845-0246
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Cough Plus Bronchial
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Antimonium Tartaricum, Arum Triphyllum, Badiaga, Baptisia Tinctoria, Bryonia (alba), Drosera (rotundifolia), Echinacea (angustifolia), Eupatorium Perfoliatum, Kali Bromatum, Lung Suis, Phosphorus, Pulsatilla (pratensis), Spongia Tosta, Sticta Pulmonaria, Sulphur Iodatum, Urtica Urens
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Liddell Laboratories, Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Spray
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ANEMONE PRATENSIS - 30 [hp_C]/mL
ANTIMONY POTASSIUM TARTRATE - 200 [hp_C]/mL
ARISAEMA TRIPHYLLUM ROOT - 30 [hp_C]/mL
BAPTISIA TINCTORIA ROOT - 3 [hp_X]/mL
BRYONIA ALBA ROOT - 200 [hp_C]/mL
DROSERA ROTUNDIFOLIA - 3 [hp_X]/mL
ECHINACEA ANGUSTIFOLIA - 3 [hp_X]/mL
EUPATORIUM PERFOLIATUM FLOWERING TOP - 200 [hp_C]/mL
LOBARIA PULMONARIA - 200 [hp_C]/mL
PHOSPHORUS - 30 [hp_C]/mL
POTASSIUM BROMIDE - 6 [hp_X]/mL
SILICON DIOXIDE - 12 [hp_X]/mL
SPONGIA OFFICINALIS SKELETON, ROASTED - 12 [hp_X]/mL
SPONGILLA LACUSTRIS - 12 [hp_X]/mL
SULFUR IODIDE - 200 [hp_C]/mL
SUS SCROFA LUNG - 6 [hp_X]/mL
URTICA URENS - 200 [hp_C]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 09 Apr, 2019
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 10 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Liddell Laboratories, Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:8E272251DI
DL6OZ476V3
DM64K844DM
5EF0HWI5WU
T7J046YI2B
QR44N9XPJQ
VB06AV5US8
1W0775VX6E
D1YM0P5Z2T
27YLU75U4W
OSD78555ZM
ETJ7Z6XBU4
1PIP394IID
6SZ0G98BHM
L6L8KA2AA0
7GL3G1COB3
IHN2NQ5OF9
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
50845-0246-130 mL in 1 BOTTLE, SPRAY (50845-0246-1)09 Apr, 2019N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Uses: may temporarily relieve these symptoms associated with cough and bronchial congestion: • coughing • mucous buildup • chest tightness • chest soreness** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Product Elements:

Cough plus bronchial antimonium tartaricum, arum triphyllum, badiaga, baptisia tinctoria, bryonia (alba), drosera (rotundifolia), echinacea (angustifolia), eupatorium perfoliatum, kali bromatum, lung suis, phosphorus, pulsatilla (pratensis), spongia tosta, sticta pulmonaria, sulphur iodatum, urtica urens antimony potassium tartrate antimony cation (3+) arisaema triphyllum root arisaema triphyllum root spongilla lacustris spongilla lacustris baptisia tinctoria root baptisia tinctoria root bryonia alba root bryonia alba root drosera rotundifolia drosera rotundifolia echinacea angustifolia echinacea angustifolia eupatorium perfoliatum flowering top eupatorium perfoliatum flowering top potassium bromide bromide ion sus scrofa lung sus scrofa lung phosphorus phosphorus anemone pratensis anemone pratensis silicon dioxide silicon dioxide spongia officinalis skeleton, roasted spongia officinalis skeleton, roasted lobaria pulmonaria lobaria pulmonaria sulfur iodide sulfur iodide urtica urens urtica urens water alcohol

Indications and Usage:

Indications: may temporarily relieve these symptoms associated with cough and bronchial congestion: • coughing • mucous buildup • chest tightness • chest soreness** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Warnings:

Warnings: do not use if you have ever had an allergic reaction to this product or any of its ingredients. stop use and ask a doctor if cough persists for more than one (1) week, tends to recur, or if it is accompanied by fever, rash or by persistent headache. a persistent cough may be a sign of a serious condition. keep out of reach of children. in case of overdose, get medical help or call a poison control center right away. if pregnant or breast feeding, ask a doctor before using product. do not use if tamper evident seal around neck of bottle is missing or broken. other information store at room temperature.

Dosage and Administration:

Directions: adults and children over 12 spray twice under the tongue three times per day. for severe symptoms, dosage may be taken up to six times the first day. children 12 and under consult a doctor prior to use.

Package Label Principal Display Panel:

Package label display: oral sprays liddell laboratories est. 1994 06 cb cough + bronchial may relieve cough + bronchial symptoms: coughing, mucous buildup, chest tightness + chest soreness. homeopathic doctor formulated readily absorbed. safe. no known side effects. easy to use. 1.0 fl oz. (30 ml) cough + bronchial lbl cough + bronchial ctn

Further Questions:

Questions: dist. by liddell laboratories inc. woodbine, ia 51579 www.liddell.net 1-800-460-7733


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.